Cumberland Pharmaceuticals Inc.
corporate_fare Company Profile
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for CPIX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 11 rated 8 or above. Recent SEC coverage for CPIX spans 10-Q, 8-K, DEFM14A, PREM14A.
Recent high-impact activity:
- Cumberland 10-Q: $80.6M Cash After Apotex Deal, Continuing Ops Still Burning $1.9M a Quarter
- Cumberland Posts $77.8M Q3 Net Income on Divestiture Gain; $80.6M Cash
- Cumberland Posts $77.8M Q3 Profit, Confirms Rolling NDA for DMD Cardiomyopathy
- Cumberland to File Rolling NDA for Ifetroban in DMD Cardiomyopathy Despite FDA Efficacy Concerns
- Cumberland Picks Rolling NDA Path for Ifetroban in DMD Heart Disease
Financial Snapshot
Short Interest & Short Volume
1.75 days to coverFINRA reported short interest of 300,312 shares in CPIX as of the October 30, 2026 settlement, a 10.6% decrease from the prior period — about 1.8 days to cover at its recent average daily volume. On November 20, 2026, 36.7% of CPIX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.